发明名称 |
Methods of treating a <i>Flaviviridae </i>family viral infection and compositions for treating a <i>Flaviviridae </i>family viral infection |
摘要 |
Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of treating HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like. |
申请公布号 |
US9061010(B2) |
申请公布日期 |
2015.06.23 |
申请号 |
US200812677989 |
申请日期 |
2008.09.18 |
申请人 |
The Board of Trustees of the Leland Stanford Junior University |
发明人 |
Einav Shirit;Glenn Jeffrey S.;McDowell Robert;Yang Wenjin;Dvory-Sobol Hadas |
分类号 |
A61K31/415;A61K31/4184;A61K31/67;A61K31/7056;A61K45/06;C07K14/005;A61K38/21;C07D235/08;C07D235/12 |
主分类号 |
A61K31/415 |
代理机构 |
Thomas Horstemeyer, LLP |
代理人 |
Thomas Horstemeyer, LLP |
主权项 |
1. A method of treating a host infected with Hepatitis C virus, the method comprising administering to the host a therapeutically effective amount of an inhibiting agent, or a pharmaceutical salt thereof, to reduce the viral load in the host, wherein the inhibiting agent is a compound having the formula: wherein R1 is selected from the group consisting of R2 is selected from the group consisting of: —H, —CH3, —CF3, —CH2CH3, CH2OH,and
R4 to R7 are each independently selected from the group consisting of: —H, —CH3, and a halogen. |
地址 |
Palo Alto CA US |